One form of hair loss that affects approximately two percent of the population is getting new hope thanks to an FDA approved drug that is helping those with this condition restore their hair.

Alopecia Areata is an autoimmune skin disease that causes someone to lose hair from their scalp - anywhere from small circles randomly around the scalp to an entirely bald head, and loss of body hair.

The disease and the degree to which it affects someone is different for each person. But researchers from CUMC have discovered that a new FDA approved drug is successful in inhibiting the immune cells that cause this type of autoimmune hair loss.

Many people who are part of the clinical trial have seen complete hair regrowth ranging from just moderate sufferers to even those with severe cases of Alopecia Areata.

Some of those patients using the medicine saw hair regrowth in just five months of treatment. Specifically, the reports that the researchers "tried two JAK inhibitors, a new class of drugs, Ruxolitinib and Tofacitinib to block the immune pathways found in the research and to stop the attacks of the hair follicles by the T cells."

While testing is still being done to prove its absolute effectiveness to assist with hair loss for those who are diagnosed specifically with these autoimmune diseases, the results are already bringing hope to patients and doctors. Success in this area of medical research offers a grain of hope that through further research and better understanding of disease, cures for many ailments, may be on the way.